Rafferty Asset Management, LLC
Position in CATX — Perspective Therapeutics, Inc.
CIK 1389426
New York, NY
Position in CATX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$387,026
-$963,166 QoQ
Shares Held
92,812
-8.2% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $73,438,449 across 11 Medical Devices names. CATX ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GEHC |
GE HealthCare Technologies Inc.
|
202,246 | $14,395,870 | |
| 2 | ABT |
Abbott Laboratories
|
134,369 | $13,795,665 | |
| 3 | DXCM |
Dexcom Inc
|
199,829 | $12,549,261 | |
| 4 | SYK |
Stryker Corp
|
26,612 | $8,744,437 | |
| 5 | MDT |
Medtronic plc
|
99,066 | $8,584,068 | |
| 6 | BSX |
Boston Scientific Corp
|
114,594 | $7,190,773 | |
| 7 | EW |
Edwards Lifesciences Corp
|
44,842 | $3,590,947 | |
| 8 | STE |
STERIS plc
|
7,577 | $1,675,502 |
All Filings in CATX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $387,026 | 92,812 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $1,350,192 | 101,138 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||